ロード中...
High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection
BACKGROUND: RCTs demonstrated the newest LTBI regimen, 12 weekly doses of directly observed isoniazid and rifapentine (3HP), as efficacious as 9 months of isoniazid (9H) with a greater completion rate (82% versus 69%); however, 3HP has not been assessed in routine health care settings. METHODS: Obse...
保存先:
| 出版年: | Clin Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5709238/ https://ncbi.nlm.nih.gov/pubmed/28575208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix505 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|